Production (Stage)
Elanco Animal Health Incorporated
ELAN
$13.81
-$0.36-2.54%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -1.00% | -1.45% | -3.56% | 12.02% | -4.14% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.00% | -1.45% | -3.56% | 12.02% | -4.14% |
| Cost of Revenue | -1.17% | -2.91% | 1.03% | 14.06% | 4.25% |
| Gross Profit | -0.87% | 0.00% | -7.40% | 10.59% | -9.57% |
| SG&A Expenses | 1.19% | 2.44% | 3.19% | 0.28% | 3.06% |
| Depreciation & Amortization | -3.76% | -5.80% | -5.00% | -3.68% | -0.75% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.00% | -1.37% | 0.88% | 6.47% | 3.47% |
| Operating Income | -9.02% | -6.67% | -111.90% | 116.98% | -39.82% |
| Income Before Tax | 400.00% | 59.84% | 150.96% | 59.49% | -88.89% |
| Income Tax Expenses | 65.00% | -407.14% | 19,600.00% | 0.00% | -500.00% |
| Earnings from Continuing Operations | 109.38% | 94.33% | 133.21% | 48.45% | -68.93% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 109.38% | 94.33% | 133.21% | 48.45% | -68.93% |
| EBIT | -9.02% | -6.67% | -111.90% | 116.98% | -39.82% |
| EBITDA | -5.69% | 4.55% | -23.26% | 20.43% | -24.11% |
| EPS Basic | 108.47% | 94.34% | 133.10% | 48.60% | -69.05% |
| Normalized Basic EPS | 18.50% | 44.18% | -63.43% | 264.95% | -60.99% |
| EPS Diluted | 116.67% | 93.26% | 132.82% | 49.40% | -71.39% |
| Normalized Diluted EPS | 18.19% | 44.18% | -62.42% | 264.95% | -61.05% |
| Average Basic Shares Outstanding | 0.39% | 0.32% | 0.32% | 0.32% | 0.43% |
| Average Diluted Shares Outstanding | 0.63% | 0.32% | 1.01% | 0.32% | 0.65% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |